LEVOCETIRIZINE DIHYDROCHLORIDE
- Manufacturer
- Sincerus Florida, LLC | Sincerus Florida. LLC
- Effective date
- 2019-05-14
- Label type
- HUMAN PRESCRIPTION DRUG LABEL
- Version
- 1
- Source
- full-release
- Hydrated at
- 2026-05-31 20:28:44
Label at a glance#
ProductLEVOCETIRIZINE DIHYDROCHLORIDE 2% / MUPIROCIN 2% / TRIAMCINOLONE ACETONIDE 0.025%
Active ingredientLEVOCETIRIZINE DIHYDROCHLORIDE, MUPIROCIN, TRIAMCINOLONE ACETONIDE
Label structure4 sections
Label contents#
Full prescribing information#
Sincerus Florida, LLC. Adverse reactions
Active, inactive
NDC 72934- 2137-2 LEVOCETIRIZINE DIHYDROCHLORIDE USP 2% / MUPIROCIN USP 2% / TRIAMCINOLONE ACETONIDE USP 0.025%. Cream 30gm
DailyMed Pharmacologic Classes#
| Class | Version | Type | Effective |
|---|---|---|---|
| LEVOCETIRIZINE Pharmacologic Class Indexing | 3 | Indexing - Pharmacologic Class | 20180813 |
| MUPIROCIN Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| TRIAMCINOLONE ACETONIDE Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 72934-2137-2 | 2021-01-29 | C162847 | 48780-1 | ba0f9c33-1c61-a910-e053-dadaa90a0b85 | LEVOCETIRIZINE DIHYDROCHLORIDE 2% / MUPIROCIN 2% / TRIAMCINOLONE ACETONIDE 0.025% |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 72934-2137-2 | LEVOCETIRIZINE DIHYDROCHLORIDE 2% / MUPIROCIN 2% / TRIAMCINOLONE ACETONIDE 0.025% | 30 g in 1 BOTTLE, PUMP | CREAM | 30 | 1 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 72934-2137 | LEVOCETIRIZINE DIHYDROCHLORIDE 2% / MUPIROCIN 2% / TRIAMCINOLONE ACETONIDE 0.025% CREAM [SINCERUS FLORIDA, LLC] | 1 | Legacy NDC, 1 package rows | 20190515_88debe23-e0a0-1236-e053-2a95a90ac9a6.zip |
Products#
Every source-derived product name is available through these pages.
- LEVOCETIRIZINE DIHYDROCHLORIDE 2% / MUPIROCIN 2% / TRIAMCINOLONE ACETONIDE 0.025%
- LEVOCETIRIZINE DIHYDROCHLORIDE
- LEVOCETIRIZINE
- MUPIROCIN
- TRIAMCINOLONE ACETONIDE
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 72934-2137 | 72934-2137-2 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| LEVOCETIRIZINE DIHYDROCHLORIDE | SOD6A38AGA | ACTIB |
| MUPIROCIN | D0GX863OA5 | ACTIB |
| TRIAMCINOLONE ACETONIDE | F446C597KA | ACTIB |
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 88debe23-e0a1-1236-e053-2a95a90ac9a6 | 88debe23-e0a0-1236-e053-2a95a90ac9a6 | 2019-05-14 | Adverse reactions | 88debe23-e0a1-1236-e053-2a95a90ac9a6 88debe23-e0a0-1236-e053-2a95a90ac9a6 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.


